逐痰消痹方贴剂治疗结核性胸膜炎临床疗效

Study on the clinical effect of Zhutan Xiaobi patch in the treatment of tuberculous pleurisy

目的:观察逐痰消痹方贴剂辅助治疗结核性胸膜炎的临床疗效。方法:将163例结核性胸膜炎患者随机分为治疗组85例和对照组78例。治疗组采用常规抗结核治疗(2HRZS/7HR)加患侧贴逐痰消痹方贴剂治疗,对照组采用常规抗结核治疗(2HRZS/7HR)加患侧外敷逐痰消痹方散剂并磁疗治疗。治疗后1、6个月评价两组症状缓解率、胸水吸收率。结果:治疗组和对照组的症状缓解率、胸水吸收率,治疗1个月分别为56.47%和41.02%(P>0.05)。治疗6个月分别为92.94%和74.36%(P<0.05)。结论:逐痰消痹方贴剂是使用方便,用药安全,疗效确切的辅助治疗结核性胸膜炎的外用贴剂。

Objective：To observe the clinical effects of Zhutan Xiaobi Patch in adjuvant treatment of tuberculous pleurisy.Methods：163cases of tuberculous pleurisy patients were randomly divided into treatment group（85cases）and control group（78cases）.The treatment group was treated with routine antituberculous drugs（2HRZS/7HR）plus external application of Zhutan Xiaobi patch on the affected sides,while the control group was treated with routine antituberculous drugs（2HRZS/7HR）plus external application of Zhutan Xiaobi powder on the affected sides and magnetic therapy.The symptomatic relief rate and the pleural fluid absorption rate were evaluated after one month＇s and six months＇ treatment respectively.Results：After one month＇s treatment,the symptomatic relief rate of the treatment group and the control group were 56.47% and 41.02%（P〉0.05）respectively.After six months＇ treatment,the the symptomatic relief rate of the treatment group and the control group were 92.94%and 74.36%（P〈0.05）.Conclusion：Zhutan Xiaobi patch is an effective,safe,and convenient topical patch for adjuvant treating of tuberculous pleurisy.